Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Bhanu Prasanth Koppolu
North Carolina State University Raleigh, Department: Engineering (All Types)
Should you be removed from our database? Contact us at [email protected]. Read more below.
VivImmune, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The SFIs of the investigator, who is a postdoctoral research associate, are related to the funded research since the technology being used in the project has been licensed to the company with which the Investigator has multiple relationships (co-founder with equity ownership, leadership role). The Institution has determined that since the technology could be further validated as a result of the research, these financial interests could conflict with the project.
Biopolymer-based strategies for local delivery of cytokine therapeutics
The administration of pro-inflammatory cytokines has demonstrated remarkable antitumor activity in numerous preclinical studies. Unfortunately, these cytokines have not been widely effective in humans due to the lack of effective delivery strategies which maximize appropriate cytokine levels in tumors while minimizing toxicities associated with their systemic spread. This project will overcome these limitations by developing and evaluating a novel delivery strategy, based on linking cytokines with the biodegradable polysaccharide chitosan for the local, sustained delivery of pro-inflammatory and T cell activating cytokines to the tumor microenvironment.
Filed on January 31, 2017.
Tell us what you know about Bhanu Prasanth Koppolu's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.